It has been found that the “BRAF-TFEB-autophagy-lysosome” axis represents a key regulatory pathway in BRAF mutant melanoma, leading to tumor progression, metastasis, and resistance to BRAF-targeted therapy in melanoma (Li et al., 2019a; Barceló et al., 2020). The gene discussed is BRAF; the disease is neoplasm.